{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:28:34Z","timestamp":1792895314296,"version":"4.5.0"},"reference-count":204,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In the broad range of human diseases, thrombo-inflammation appears as a clinical manifestation. Clinically, it is well characterized in context of superficial thrombophlebitis that is recognized as thrombosis and inflammation of superficial veins. However, it is more hazardous when developed in the microvasculature of injured\/inflamed\/infected tissues and organs. Several diseases like sepsis and ischemia-reperfusion can cause formation of microvascular thrombosis subsequently leading to thrombo-inflammation. Thrombo-inflammation can also occur in cases of antiphospholipid syndrome, preeclampsia, sickle cell disease, bacterial and viral infection. One of the major contributors to thrombo-inflammation is the loss of normal anti-thrombotic and anti-inflammatory potential of the endothelial cells of vasculature. This manifest itself in the form of dysregulation of the coagulation pathway and complement system, pathologic platelet activation, and increased recruitment of leukocyte within the microvasculature. The role of platelets in hemostasis and formation of thrombi under pathologic and non-pathologic conditions is well established. Platelets are anucleate cells known for their essential role in primary hemostasis and the coagulation pathway. In recent years, studies provide strong evidence for the critical involvement of platelets in inflammatory processes like acute ischemic stroke, and viral infections like Coronavirus disease 2019 (COVID-19). This has encouraged the researchers to investigate the contribution of platelets in the pathology of various thrombo-inflammatory diseases. The inhibition of platelet surface receptors or their intracellular signaling which mediate initial platelet activation and adhesion might prove to be suitable targets in thrombo-inflammatory disorders. Thus, the present review summarizes the concept and mechanism of platelet signaling and briefly discuss their role in sterile and non-sterile thrombo-inflammation, with the emphasis on role of platelets in COVID-19 induced thrombo-inflammation. The aim of this review is to summarize the recent developments in deciphering the role of the platelets in thrombo-inflammation and discuss their potential as pharmaceutical targets.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1039843","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T01:16:51Z","timestamp":1668388611000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":87,"title":["Platelet in thrombo-inflammation: Unraveling new therapeutic targets"],"prefix":"10.3389","volume":"13","author":[{"given":"Swati","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Antoniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2016.10.005","article-title":"Platelets and infection","volume":"28","author":"Deppermann","year":"2016","journal-title":"Semin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-12-1067","article-title":"The role of platelets in inflammation","volume":"114","author":"Thomas","year":"2015","journal-title":"Thromb Haemost"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI122955","article-title":"Functional significance of the platelet immune receptors GPVI and CLEC-2","volume":"129","author":"Rayes","year":"2019","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-468694","article-title":"Platelets in tissue repair: control of apoptosis and interactions with regenerative cells","volume":"122","author":"Gawaz","year":"2013","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170879","article-title":"Platelets as autonomous drones for hemostatic and immune surveillance","volume":"214","author":"Li","year":"2017","journal-title":"J Exp Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.310224","article-title":"Platelet ITAM signaling is critical for vascular integrity in inflammation","volume":"123","author":"Boulaftali","year":"2013","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2011.212886","article-title":"Inflammation induces hemorrhage in thrombocytopenia","volume":"111","author":"Goerge","year":"2008","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0061-0","article-title":"The contribution of platelet glycoprotein receptors to inflammatory bleeding prevention is stimulus and organ dependent","volume":"103","author":"Rayes","year":"2018","journal-title":"Haematologica"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12782","article-title":"Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice","volume":"126","author":"Gros","year":"2015","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-015-0092-1","article-title":"Platelets and vascular integrity: how platelets prevent bleeding in inflammation","volume":"131","author":"Ho-Tin-Noe","year":"2018","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-0209-x","article-title":"Platelet signaling pathways and new inhibitors","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00649","article-title":"Ischaemic stroke: A thrombo-inflammatory disease","volume":"589","author":"Nieswandt","year":"2011","journal-title":"J Physiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90266-X","article-title":"Platelets interact with coxsackieviruses b and have a critical role in the pathogenesis of virusinduced myocarditis","volume":"13","author":"Negrotto","year":"2015","journal-title":"J Thromb haemostasis: JTH"},{"key":"B15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1084\/jem.20012044","article-title":"Human platelets and their capacity of binding viruses: meaning and challenges","volume":"16","author":"Chabert","year":"2015","journal-title":"BMC Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.961714","article-title":"Platelets and viruses: An ambivalent relationship","volume":"67","author":"Flaujac","year":"2010","journal-title":"Cell Mol Life sciences: CMLS"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00649","article-title":"Platelets and infection - an emerging role of platelets in viral infection","volume":"5","author":"Assinger","year":"2014","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02517.x","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2010.04.009","article-title":"Increase of neutrophil adhesion and vasoconstriction with platelet deposition after deep arterial injury by angioplasty","volume":"129","author":"Merhi","year":"1995","journal-title":"Am Heart J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.573","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.302919","article-title":"Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis","volume":"122","author":"Drechsler","year":"2010","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.247684","article-title":"Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits","volume":"123","author":"Ylitalo","year":"1994","journal-title":"J Lab Clin Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02517.x","article-title":"Platelets, inflammation and atherosclerosis","volume":"5","author":"Lindemann","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-261206","article-title":"Impact of glycoprotein VI and platelet adhesion on atherosclerosis\u2013a possible role of fibronectin","volume":"49","author":"B\u00fcltmann","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/28204","article-title":"Differential inhibition of human atherosclerotic plaque-induced platelet activation by dimeric GPVI-fc and anti-GPVI antibodies: functional and imaging studies","volume":"65","author":"Jamasbi","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000170133.43608.37","article-title":"Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation","volume":"34","author":"Badrnya","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208894200","article-title":"Binding of CD40L to mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis\u2013but does not affect immunity and thrombosis in mice","volume":"109","author":"Wolf","year":"2011","journal-title":"Circ Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2012.00001","article-title":"The CD40-TRAF6 axis is the key regulator of the CD40\/CD40L system in neointima formation and arterial remodeling","volume":"111","author":"Donners","year":"2008","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1898","article-title":"Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis","volume":"116","author":"Lievens","year":"2010","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003615","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/hh1801.096339","article-title":"Platelet microparticles: A transcellular delivery system for RANTES promoting monocyte recruitment on endothelium","volume":"25","author":"Mause","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2003.13","article-title":"Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells","volume":"278","author":"Nassar","year":"2003","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/09537104.2015.1064881","article-title":"Macrophage phenotype modulation by CXCL4 in atherosclerosis","volume":"3","author":"Gleissner","year":"2012","journal-title":"Front Physiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/ATVBAHA.107.159178","article-title":"Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice","volume":"15","author":"Koenen","year":"2009","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000184765.59207.f3","article-title":"A peptide inhibitor of CXCL4-CCL5 heterodimer formation, protects against stroke in mice","volume":"5","author":"Fan","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M700211200","article-title":"Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets","volume":"89","author":"Galt","year":"2001","journal-title":"Circ Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2003.13","article-title":"Clopidogrel but not aspirin reduces p-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease","volume":"73","author":"Klinkhardt","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.089987","article-title":"The role of platelets in the recruitment of leukocytes during vascular disease","volume":"26","author":"Ed Rainger","year":"2015","journal-title":"Platelets"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.159178","article-title":"Oxidative stress and platelets","volume":"28","author":"Freedman","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-5269com","article-title":"CD40 ligand influences platelet release of reactive oxygen intermediates","volume":"25","author":"Chakrabarti","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr373","article-title":"CD40-40L signaling in vascular inflammation","volume":"282","author":"Chakrabarti","year":"2007","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.12285","article-title":"Modulation of ADP-induced platelet activation by aspirin and pravastatin: Role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling","volume":"322","author":"Marwali","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1124\/jpet.105.089987","article-title":"The effect of dipyridamole on vascular cell-derived reactive oxygen species","volume":"315","author":"Chakrabarti","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112322","article-title":"Grape seed and skin extracts inhibit platelet function and release of reactive oxygen intermediates","volume":"46","author":"Vitseva","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-287623","article-title":"Polyphenols enhance platelet nitric oxide by inhibiting protein kinase c-dependent NADPH oxidase activation: effect on platelet recruitment","volume":"20","author":"Pignatelli","year":"2006","journal-title":"FASEB J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112322","article-title":"Antiplatelet agents for the treatment and prevention of atherothrombosis","volume":"32","author":"Patrono","year":"2011","journal-title":"Eur Heart J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-287623","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Thrombosis and platelets: An update","volume":"38","author":"Koupenova","year":"2017","journal-title":"Eur Heart J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-624023","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-710632","article-title":"Von willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models","volume":"117","author":"Brill","year":"2011","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.12.075","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"Brill","year":"2012","journal-title":"J Thromb Haemost"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2018-0909","article-title":"P-selectin promotes neutrophil extracellular trap formation in mice","volume":"126","author":"Etulain","year":"2015","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-02-0113","article-title":"Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice","volume":"128","author":"Stark","year":"2016","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1038\/srep27478","article-title":"Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA","volume":"8","author":"Dyer","year":"2018","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114238","article-title":"Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development","volume":"129","author":"Subramaniam","year":"2017","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1700518","article-title":"Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism","volume":"45","author":"Chirinos","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5133","article-title":"Circulating platelet-neutrophil aggregates as risk factor for deep venous thrombosis","volume":"57","author":"Zhou","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-02-0113","article-title":"Platelets and matrix metalloproteinases","volume":"110","author":"Seizer","year":"2013","journal-title":"Thromb Haemost"},{"key":"B59","doi-asserted-by":"publisher","first-page":"27478","DOI":"10.3389\/fimmu.2019.01687","article-title":"Platelet-monocyte aggregates and c-reactive protein are associated with VTE in older surgical patients","volume":"6","author":"Shih","year":"2016","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3657","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.06.062","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl JmMed"},{"key":"B62","doi-asserted-by":"publisher","first-page":"f5133","DOI":"10.1038\/nm1565","article-title":"Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis","volume":"347","author":"Castellucci","year":"2013","journal-title":"BMJ"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000150","article-title":"Does aspirin prevent venous thromboembolism","volume":"2020","author":"Diep","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01687","article-title":"Platelets in sepsis: An update on experimental models and clinical data","volume":"10","author":"Assinger","year":"2019","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.4049\/jimmunol.1001623","article-title":"Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway","volume":"4","author":"Xiang","year":"2013","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice","volume":"28","author":"Carestia","year":"2019","journal-title":"Cell Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2631","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00023.2017","article-title":"HMGB1 promotes neutrophil extracellular trap formation through interactions with toll-like receptor 4","volume":"304","author":"Tadie","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2009.11.004","article-title":"Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation","volume":"7","author":"Kraemer","year":"2011","journal-title":"PLoS Pathog"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.044487","article-title":"Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1beta-rich microparticles","volume":"186","author":"Brown","year":"2011","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2194","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79070","article-title":"Nucleation of platelets with blood-borne pathogens on kupffer cells precedes other innate immunity and contributes to bacterial clearance","volume":"14","author":"Wong","year":"2013","journal-title":"Nat Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02402-6","article-title":"Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse","volume":"313","author":"Lax","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1995.tb01694.x","article-title":"The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes","volume":"125","author":"Beaulieu","year":"2010","journal-title":"Thromb Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.044487","article-title":"Inhibition of endotoxin response by e5564, a novel toll-like receptor 4-directed endotoxin antagonist","volume":"304","author":"Mullarkey","year":"2003","journal-title":"J Pharm Exp"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: The ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.07.002","article-title":"Inflammation drives thrombosis after salmonella infection via CLEC-2 on platelets","volume":"125","author":"Hitchcock","year":"2015","journal-title":"J Clin Invest"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1080\/10739680490266216","article-title":"The podoplanin-CLEC-2 axis inhibits inflammation in sepsis","volume":"8","author":"Rayes","year":"2017","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200106000-00019","article-title":"Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure","volume":"25","author":"Gawaz","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.4078","article-title":"Novel aspects of antiplatelet therapy in cardiovascular disease","volume":"2","author":"Gremmel","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041549","article-title":"Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice","volume":"62","author":"Slaba","year":"2015","journal-title":"Hepatology"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0315","article-title":"Use of antiplatelet agents in sepsis: A glimpse into the future","volume":"133","author":"Akinosoglou","year":"2014","journal-title":"Thromb Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4049\/jimmunol.1102674","article-title":"Glycoprotein IIB\/IIIA-inhibition and microcirculatory alterations during experimental endotoxemia\u2013an intravital microscopic study in the rat","volume":"11","author":"Walther","year":"2004","journal-title":"Microcirculation"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-841593","article-title":"Beneficial effect of glycoprotein IIb\/IIIa inhibitor (AZ-1) on endothelium in escherichia coli endotoxin-induced shock","volume":"29","author":"Pu","year":"2001","journal-title":"Crit Care Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3226","article-title":"7E3 F(ab9)2, a monoclonal antibody to the platelet GPIIb\/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of escherichia coli","volume":"89","author":"Taylor","year":"1997","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.06.087","article-title":"Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb\/IIIa blockade","volume":"7","author":"Sharron","year":"2012","journal-title":"PLoS One"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2018.12.009","article-title":"A TREM family member, TLT-1, is found exclusively in the alpha-granules of megakaryocytes and platelets","volume":"104","author":"Washington","year":"2004","journal-title":"Blood"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1177\/1753425913508992","article-title":"Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis","volume":"188","author":"Derive","year":"2012","journal-title":"J Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.07.003","article-title":"Platelet-derived TLT-1 is a prognostic indicator in ALI\/ARDS and prevents tissue damage in the lungs in a mouse model","volume":"132","author":"Morales-Ort\u00edz","year":"2018","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3226","article-title":"Annual summary of vital statistics: 2005","volume":"119","author":"Hamilton","year":"2007","journal-title":"Pediatrics"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.06.087","article-title":"Co-Morbidities associated with influenza-attributed mortality, 1994\u20132000, Canada","volume":"26","author":"Schanzer","year":"2008","journal-title":"Vaccine"},{"key":"B92","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bj.2018.12.009","article-title":"The dual role of innate immunity during influenza","volume":"42","author":"Biondo","year":"2019","journal-title":"BioMed J"},{"key":"B93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1753425913508992","article-title":"The amazing innate immune response to influenza a virus infection","volume":"21","author":"Tripathi","year":"2015","journal-title":"Innate Immun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.07.003","article-title":"Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2","volume":"13","author":"Manna","year":"2020","journal-title":"J Infect Public Health"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00422-16","article-title":"Influenza a virus infection predisposes hosts to secondary infection with different streptococcus pneumoniae serotypes with similar outcome but serotype-specific manifestation","volume":"84","author":"Sharma-Chawla","year":"2016","journal-title":"Infect Immun"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12109","article-title":"The coagulation system in host defense","volume":"2","author":"Antoniak","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"B97","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00018-009-0205-1","article-title":"Platelets and innate immunity","volume":"67","author":"Semple","year":"2010","journal-title":"Cell MolLife Sci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2021.1887842","article-title":"Platelets and viruses","volume":"32","author":"Antoniak","year":"2021","journal-title":"Platelets"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/s41467-019-09607-x","article-title":"The role of platelets in mediating a response to human influenza infection","volume":"10","author":"Koupenova","year":"2019","journal-title":"Nat Commun"},{"key":"B100","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3389\/fimmu.2021.772859","article-title":"Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia","volume":"61","author":"Pulavendran","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201406-1031OC","article-title":"Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis","volume":"191","author":"Le","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-536003","article-title":"In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1)","volume":"141","author":"Rondina","year":"2012","journal-title":"Chest"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12842","article-title":"Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis","volume":"12","author":"McDonald","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1182\/blood2011-01-332676","article-title":"Histones induce rapid and profound thrombocytopenia in mice","volume":"118","author":"Fuchs","year":"2011","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.772859","article-title":"Platelet-mediated NET release amplifies coagulopathy and drives lung pathology during severe influenza infection","volume":"12","author":"Kim","year":"2021","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-515536","article-title":"Influenza virus H1N1 activates platelets through fc RIIA signaling and thrombin generation","volume":"123","author":"Boilard","year":"2014","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Platelet-tlr7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis","volume":"124","author":"Koupenova","year":"2014","journal-title":"Blood"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/35025229","article-title":"Expression and functionality of toll-like receptor 3 in the megakaryocytic lineage","volume":"13","author":"D'Atri","year":"2015","journal-title":"J Thromb Haemost"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.103949","article-title":"Human platelets express toll-like receptor 3 and respond to poly i:C","volume":"75","author":"Anabel","year":"2014","journal-title":"Hum Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1172\/JCI66125","article-title":"PAR-1 contributes to the innate immune response during viral infection","volume":"123","author":"Antoniak","year":"2013","journal-title":"J Clin Invest"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61667","article-title":"PAR1 contributes to influenza a virus pathogenicity in mice","volume":"123","author":"Khoufache","year":"2013","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01377.x65","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.103949","article-title":"Protease-activated receptor 4 protects mice from coxsackievirus B3 and H1N1 influenza a virus infection","volume":"344","author":"Tatsumi","year":"2019","journal-title":"Cell Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1651","article-title":"P2Y12 receptor modulates sepsis-induced inflammation","volume":"36","author":"Liverani","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.01.058","article-title":"Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness","volume":"35","author":"Gross","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.05.005","article-title":"Ticagrelor reduces thromboinflammatory markers in patients with pneumonia","volume":"3","author":"Sexton","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.molimm.2017.08.026","article-title":"Platelet-neutrophil-interactions: linking hemostasis and inflammation","volume":"21","author":"Zarbock","year":"2007","journal-title":"Blood Rev"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29153","article-title":"Increased neutrophil-platelet \u00a8 adhesion in patients with unstable angina","volume":"94","author":"Ott","year":"1996","journal-title":"Circulation"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1651","article-title":"Existence of a microRNA pathway in anucleate platelets","volume":"16","author":"Landry","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2019.12.016","article-title":"MicroRNA-223 suppresses the canonical NF-\u03baB pathway in basal keratinocytes to dampen neutrophilic inflammation","volume":"22","author":"Zhou","year":"2018","journal-title":"Cell Rep"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042971","article-title":"Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1\u03b2 production in macrophages by targeting STAT3","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2017.08.026","article-title":"Downregulated expression of miR-223 promotes toll-like receptor-activated inflammatory responses in macrophages by targeting RhoB","volume":"91","author":"Zhang","year":"2017","journal-title":"Mol Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015432","article-title":"Hepatic mitochondrial DNA\/Toll-like receptor 9\/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice","volume":"66","author":"He","year":"2017","journal-title":"Hepatology"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa062","article-title":"Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report","volume":"26","author":"Chyrchel","year":"2015","journal-title":"Platelets"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.06.20050575","article-title":"Platelet-derived miRNAs as determinants of the antiplatelet response in clopidogrel-treated patients with ACS","volume":"186","author":"Liu","year":"2020","journal-title":"Thromb Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.05.025","article-title":"The role of platelets in acute lung injury (ALI)","volume":"14","author":"Zarbock","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.10478","article-title":"First-inman study with inclacumab, a human monoclonal antibody against p-selectin","volume":"65","author":"Schmitt","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1744185","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-00469-1","article-title":"COVID-19 autopsies, Oklahoma, USA","volume":"153","author":"Barton","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319117","article-title":"Pulmonary and cardiac pathology in covid-19: The first autopsy series from new Orleans","volume":"8","year":"2020","journal-title":"medRxiV"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.05.025","article-title":"Severe arterial thrombosis associated with covid-19 infection","volume":"192","author":"Kashi","year":"2020","journal-title":"Thromb Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.10478","article-title":"Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19)","volume":"3","author":"Nahum","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1744185","article-title":"COVID-19 induced coagulopathy (CIC): Thrombotic manifestations of viral infection","volume":"6","author":"Sharma","year":"2022","journal-title":"TH Open"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2020.10.003","article-title":"Thrombocytopathy and endotheliopathy are key contributors to COVID-19 thromboinflammation","volume":"18","author":"Gu","year":"2021","journal-title":"Nat Rev Cardio"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319117","article-title":"SARS-CoV-2 initiates programmed cell death in platelets","volume":"129","author":"Koupenova","year":"2021","journal-title":"Circ Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12642","article-title":"The ongoing enigma of SARS-CoV-2 and platelet interaction","volume":"6","author":"Zaid","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101695","article-title":"The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin \u03b15\u03b21 and NF-\u03baB signaling","volume":"298","author":"Robles","year":"2022","journal-title":"J Biol Chem"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101710","article-title":"Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2","volume":"298","author":"Liu","year":"2022","journal-title":"J Biol Chem"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacbts.2020.10.003","article-title":"The integrin binding peptide, ATN-161, as a novel therapy for SARS-CoV-2 infection","volume":"6","author":"Beddingfield","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201701068R","article-title":"A critical role for both CD40 and VLA5 in angiotensin II-mediated thrombosis and inflammation","volume":"32","author":"Senchenkova","year":"2018","journal-title":"FASEB J"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1749438","article-title":"The pathogenesis and treatment of the `Cytokine storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"key":"B144","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2020.08.017","article-title":"COVID-19 versus HIT hypercoagulability","volume":"196","author":"Warkentin","year":"2020","journal-title":"Thromb Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15262","article-title":"COVID-19 patients often show high-titer non-Platelet-Activating anti-PF4\/heparin IgG antibodies","volume":"19","author":"Brodard","year":"2021","journal-title":"J Thromb Haemost JTH"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007252","article-title":"Altered expression of platelet p roteins and calpain activity mediate hypoxia-induced prothrombotic phenotype","volume":"123","author":"Tyagi","year":"2014","journal-title":"Blood"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315175","article-title":"Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19","volume":"6","author":"Garcia","year":"2022","journal-title":"Blood Adv"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.29.21256354","article-title":"The platelet lipidome is altered in patients with COVID-19 and correlates with platelet reactivity","volume":"122","author":"Schuurman","year":"2022","journal-title":"Thromb Haemost"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007444","article-title":"Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells","volume":"6","author":"Puhm","year":"2021","journal-title":"Blood Adv"},{"key":"B150","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41420-022-01122-1","article-title":"Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19","volume":"8","author":"Trugilho","year":"2022","journal-title":"Cell Death Discov"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315175","article-title":"Platelets promote thromboinflammation in SARS-CoV-2 pneumonia","volume":"40","author":"Taus","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.29.21256354","article-title":"Understanding microvascular thrombosis in COVID-19 via massive single-cell imaging of circulating platelets","author":"Kanno","year":"2021","journal-title":"medRxiv"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008762","article-title":"Antibody-induced procoagulant platelets in severe COVID-19 infection","volume":"137","author":"Althaus","year":"2021","journal-title":"Blood"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007008","article-title":"A biosafety level 2 mouse model for studying betacoronavirus-induced acute lung damage and systemic manifestations","volume":"95","author":"Andrade","year":"2021","journal-title":"J Virol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1186\/1556-276X-9-60","article-title":"Crystallographic order and decomposition of [MnIII6CrIII]3+ single-molecule magnets deposited in submonolayers and monolayers on HOPG studied by means of molecular resolved atomic force microscopy (AFM) and kelvin probe force microscopy in UHV","volume":"9","author":"Gryzia","year":"2014","journal-title":"Nanoscale Res Lett"},{"key":"B157","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S2352-3026(20)30109-5","article-title":"Platelet granule exocytosis: A comparison with chromaffin cells","volume":"4","author":"Fitch-Tewfik","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00042","article-title":"The non-hemostatic aspects of transfused platelets","volume":"5","author":"Sut","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317703","article-title":"Platelets can associate with SARS-CoV-2 RNA and are hyperactivated in COVID-19","volume":"127","author":"Zaid","year":"2020","journal-title":"Circ Res"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15587","article-title":"Neutrophil extracellular traps (NETs) contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"B161","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12985-021-01680-3","article-title":"Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection","volume":"18","author":"Hamzeh-Cognasse","year":"2021","journal-title":"Virol J"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.01.442279","article-title":"Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19","volume":"7","author":"Wang","year":"2020","journal-title":"Lancet Haematol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011871","article-title":"Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets","volume":"138","author":"Bye","year":"2021","journal-title":"Blood"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15587","article-title":"Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent","volume":"20","author":"Pelzl","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.10.005","article-title":"Integrin alphaIIb-mediated PI3K\/Akt activation in platelets","volume":"7","author":"Niu","year":"2012","journal-title":"PLoS One"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.834988","article-title":"Signaling through Fc\u03b3RIIA and the C5a-C5aR pathway mediate platelet hyperactivation in COVID-19","volume":"13","author":"Apostolidis","year":"2021","journal-title":"Front Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30144-0","article-title":"Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials","volume":"93","author":"Bussel","year":"2018","journal-title":"Am J Hematol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/s41467-021-22781-1","article-title":"Platelets and immune responses during thromboinflammation front","volume":"10","author":"Mezger","year":"2019","journal-title":"Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03744-4","article-title":"Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease","volume":"238","author":"Patzelt","year":"2015","journal-title":"Atherosclerosis"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/sciadv.abl8213","article-title":"Vascular disease and thrombosis in SARS-CoV-2-Infected rhesus macaques","volume":"183","author":"Aid","year":"2020","journal-title":"Cell"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15862","article-title":"Complement and tissue factor\u2013enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J Clin Invest"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Viral presence and immunopathology in patients with lethal COVID-19: A prospective autopsy cohort study","volume":"1","author":"Schurink","year":"2020","journal-title":"Lancet Microbe"},{"key":"B174","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1182\/blood.2021012819","article-title":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection","volume":"12","author":"Diao","year":"2021","journal-title":"Nat Commun"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci Adv"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15862","article-title":"Quantitative interpretation of PF4\/heparin-EIA optical densities in predicting platelet-activating VITT antibodies","volume":"20","author":"Sch\u00f6nborn","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection","volume":"121","author":"McGonagle","year":"2021","journal-title":"J Autoimmun"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012819","article-title":"Cooling down VITT with IVIG","volume":"138","author":"Lentz","year":"2021","journal-title":"Blood"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012277","article-title":"Antiplatelet drugs block platelet activation by VITT patient serum","volume":"138","author":"Smith","year":"2021","journal-title":"Blood"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.610132","article-title":"Repurposing simeprevir, calpain inhibitor IV and a cathepsin f inhibitor against SARS-CoV-2 and insights into their interactions with mpro","volume":"40","author":"Abhithaj","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01344","article-title":"Inhibition of calpain blocks platelet secretion, aggregation, and spreading","volume":"274","author":"Croce","year":"1999","journal-title":"J Biol Chem"},{"key":"B183","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats","volume":"73","author":"Wingrave","year":"2003","journal-title":"J Neurosci Res"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.10.20033522","article-title":"Involvement of calpain in the neuropathogenesis of alzheimer\u2019s disease","volume":"39","author":"Mahaman","year":"2019","journal-title":"Med Res Rev"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.784214","article-title":"Montelukast inhibits platelet activation induced by plasma from COVID-19 patients","volume":"13","author":"Camera","year":"2022","journal-title":"Front Pharmacol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.610132","article-title":"The leukotriene receptor antagonist montelukast as a potential COVID-19 therapeutic","volume":"7","author":"Aigner","year":"2020","journal-title":"Front Mol Biosci"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0140-6736(15)00667-4","article-title":"Montelukast drug may improve COVID-19 prognosis: A review of evidence","volume":"11","author":"Barr\u00e9","year":"2020","journal-title":"Front Pharmacol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16209","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.10.20033522","article-title":"Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19","author":"Lei","year":"2020","journal-title":"medRxiv"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.218545","article-title":"Low-dose btk inhibitors selectively block platelet activation by CLEC-2","volume":"106","author":"Nicolson","year":"2021","journal-title":"Haematologica"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.192328","article-title":"Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2","volume":"103","author":"Barr","year":"2018","journal-title":"Haematologica"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00667-4","article-title":"Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: An international, randomised, open-label, phase 3 study","volume":"387","author":"Dreyling","year":"2016","journal-title":"Lancet"},{"key":"B193","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/bjh.16209","article-title":"Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib","volume":"187","author":"Kander","year":"2019","journal-title":"Br J Haematol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-583294","article-title":"Ibrutinib treatment affects collagen and von willebrand factor-dependent platelet functions","volume":"124","author":"Levade","year":"2014","journal-title":"Blood"},{"key":"B195","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1038\/ncomms8360","article-title":"Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury","volume":"6","author":"Ito","year":"2015","journal-title":"Nat Commun"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008666","article-title":"Uncoupling of platelet granule release and integrin activation suggests GPIIb\/IIIa as therapeutic target in COVID-19","author":"Weiss","year":"2022","journal-title":"Blood Adv"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1186\/1477-9560-2-1","article-title":"The antithrombotic profile of aspirin. aspirin resistance, or simply failure","volume":"2","author":"Altman","year":"2004","journal-title":"Thromb J"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19158977","article-title":"Ideal P2Y12 inhibitor in acute coronary syndrome: A review and current status","volume":"19","author":"Pradhan","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B200","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11239-012-0750-6","article-title":"Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program","volume":"34","author":"O'Donoghue","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000390","article-title":"Improving outcomes in cardiovascular diseases: A review on vorapaxar","volume":"30","author":"Chaudhary","year":"2022","journal-title":"Cardiol Rev"},{"key":"B202","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/1753944713487781","article-title":"Update on platelet glycoprotein IIb\/IIIa inhibitors: recommendations for clinical practice","volume":"7","author":"Mu\u00f1iz-Lozano","year":"2013","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666201001125604","article-title":"Potential therapeutic benefits of dipyridamole in COVID-19 patients","volume":"27","author":"Aliter","year":"2021","journal-title":"Curr Pharm Des"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1177\/10600280211073009","article-title":"Antiplatelet use in ischemic stroke","volume":"56","author":"Kamarova","year":"2022","journal-title":"Ann Pharmacother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1039843\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T01:16:54Z","timestamp":1668388614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1039843\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":204,"alternative-id":["10.3389\/fimmu.2022.1039843"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1039843","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"article-number":"1039843"}}